Clinical Trial

Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth Restriction

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The local literature lacks comprehensive information regarding the actual incidence of intrauterine growth restriction (IUGR) and oligohydramnios and currently available therapeutic options. Therefore, the current study was planned with the objective to evaluate the impact of enoxaparin therapy compared with standard management on neonatal outcomes in pregnancies complicated by intrauterine growth restriction (IUGR) with oligohydramnios.
Trial Details
NCT Number NCT07462182
Lead Sponsor Muhammad Aamir Latif
Conditions Intrauterine Growth Restriction
Enrollment 108 participants
Start Date 2026-04-01
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-10